vs
Equinix（EQIX）与Solventum（SOLV）财务数据对比。点击上方公司名可切换其他公司
Equinix的季度营收约是Solventum的1.2倍（$2.4B vs $2.0B），Equinix净利率更高（11.0% vs 3.2%，领先7.8%），Equinix同比增速更快（8.8% vs -3.7%），过去两年Equinix的营收复合增速更高（5.9% vs -0.4%）
Equinix是总部位于美国加利福尼亚州雷德伍德城的跨国企业，主营互联网连接服务与数据中心托管业务，旗下数据中心此前常被业内称为“运营商酒店”，2015年1月公司正式转型为房地产投资信托基金（REIT）。
Solventum是一家总部位于美国的医疗健康企业，于2024年4月1日正式从全球知名多元化工业集团3M分拆后独立运营，继承了原3M旗下医疗板块的技术积累与业务资源，面向全球市场提供专业医疗相关产品及服务。
EQIX vs SOLV — 直观对比
营收规模更大
EQIX
是对方的1.2倍
$2.0B
营收增速更快
EQIX
高出12.5%
-3.7%
净利率更高
EQIX
高出7.8%
3.2%
两年增速更快
EQIX
近两年复合增速
-0.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.4B | $2.0B |
| 净利润 | $265.0M | $63.0M |
| 毛利率 | 50.5% | 51.4% |
| 营业利润率 | 17.4% | 6.3% |
| 净利率 | 11.0% | 3.2% |
| 营收同比 | 8.8% | -3.7% |
| 净利润同比 | -22.7% | 103.2% |
| 每股收益（稀释后） | $2.70 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EQIXSOLV
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.4B | $2.0B | ||
| Q3 25 | $2.3B | $2.1B | ||
| Q2 25 | $2.3B | $2.2B | ||
| Q1 25 | $2.2B | $2.1B | ||
| Q4 24 | $2.3B | $2.1B | ||
| Q3 24 | $2.2B | $2.1B | ||
| Q2 24 | $2.2B | $2.1B |
净利润EQIXSOLV
| Q1 26 | $265.0M | — | ||
| Q4 25 | $265.0M | $63.0M | ||
| Q3 25 | $374.0M | $1.3B | ||
| Q2 25 | $368.0M | $90.0M | ||
| Q1 25 | $343.0M | $137.0M | ||
| Q4 24 | $-14.0M | $31.0M | ||
| Q3 24 | $297.0M | $122.0M | ||
| Q2 24 | $301.0M | $89.0M |
毛利率EQIXSOLV
| Q1 26 | 50.5% | — | ||
| Q4 25 | 50.5% | 51.4% | ||
| Q3 25 | 50.7% | 54.2% | ||
| Q2 25 | 52.0% | 54.4% | ||
| Q1 25 | 51.3% | 53.8% | ||
| Q4 24 | 47.1% | 53.9% | ||
| Q3 24 | 50.1% | 56.0% | ||
| Q2 24 | 49.9% | 54.6% |
营业利润率EQIXSOLV
| Q1 26 | 17.4% | — | ||
| Q4 25 | 17.4% | 6.3% | ||
| Q3 25 | 20.5% | 80.6% | ||
| Q2 25 | 21.9% | 9.9% | ||
| Q1 25 | 20.6% | 7.3% | ||
| Q4 24 | 4.6% | 6.6% | ||
| Q3 24 | 19.3% | 13.2% | ||
| Q2 24 | 20.2% | 11.7% |
净利率EQIXSOLV
| Q1 26 | 11.0% | — | ||
| Q4 25 | 11.0% | 3.2% | ||
| Q3 25 | 16.1% | 60.4% | ||
| Q2 25 | 16.3% | 4.2% | ||
| Q1 25 | 15.4% | 6.6% | ||
| Q4 24 | -0.6% | 1.5% | ||
| Q3 24 | 13.5% | 5.9% | ||
| Q2 24 | 13.9% | 4.3% |
每股收益（稀释后）EQIXSOLV
| Q1 26 | $2.70 | — | ||
| Q4 25 | $2.70 | $0.37 | ||
| Q3 25 | $3.81 | $7.22 | ||
| Q2 25 | $3.75 | $0.51 | ||
| Q1 25 | $3.50 | $0.78 | ||
| Q4 24 | $-0.19 | $0.18 | ||
| Q3 24 | $3.10 | $0.70 | ||
| Q2 24 | $3.16 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.2B | $878.0M |
| 总债务越低越好 | — | $5.0B |
| 股东权益账面价值 | $14.2B | $5.0B |
| 总资产 | $40.1B | $14.3B |
| 负债/权益比越低杠杆越低 | — | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资EQIXSOLV
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $878.0M | ||
| Q3 25 | $2.9B | $1.6B | ||
| Q2 25 | $4.5B | $492.0M | ||
| Q1 25 | $3.7B | $534.0M | ||
| Q4 24 | $3.6B | $762.0M | ||
| Q3 24 | $3.2B | $772.0M | ||
| Q2 24 | $2.0B | $897.0M |
总债务EQIXSOLV
| Q1 26 | — | — | ||
| Q4 25 | — | $5.0B | ||
| Q3 25 | $17.3B | $5.1B | ||
| Q2 25 | $18.1B | $7.8B | ||
| Q1 25 | $15.9B | $7.9B | ||
| Q4 24 | $15.3B | $8.0B | ||
| Q3 24 | $15.4B | $8.1B | ||
| Q2 24 | $14.5B | $8.3B |
股东权益EQIXSOLV
| Q1 26 | $14.2B | — | ||
| Q4 25 | $14.2B | $5.0B | ||
| Q3 25 | $14.2B | $5.0B | ||
| Q2 25 | $14.1B | $3.6B | ||
| Q1 25 | $13.9B | $3.3B | ||
| Q4 24 | $13.5B | $3.0B | ||
| Q3 24 | $13.6B | $3.2B | ||
| Q2 24 | $12.3B | $2.9B |
总资产EQIXSOLV
| Q1 26 | $40.1B | — | ||
| Q4 25 | $40.1B | $14.3B | ||
| Q3 25 | $38.1B | $14.0B | ||
| Q2 25 | $38.8B | $15.1B | ||
| Q1 25 | $36.1B | $14.5B | ||
| Q4 24 | $35.1B | $14.5B | ||
| Q3 24 | $35.4B | $14.7B | ||
| Q2 24 | $32.9B | $14.6B |
负债/权益比EQIXSOLV
| Q1 26 | — | — | ||
| Q4 25 | — | 1.00× | ||
| Q3 25 | 1.22× | 1.03× | ||
| Q2 25 | 1.28× | 2.14× | ||
| Q1 25 | 1.14× | 2.43× | ||
| Q4 24 | 1.13× | 2.71× | ||
| Q3 24 | 1.13× | 2.54× | ||
| Q2 24 | 1.18× | 2.90× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $95.0M |
| 自由现金流经营现金流 - 资本支出 | — | $32.0M |
| 自由现金流率自由现金流/营收 | — | 1.6% |
| 资本支出强度资本支出/营收 | — | 3.2% |
| 现金转化率经营现金流/净利润 | — | 1.51× |
| 过去12个月自由现金流最近4个季度 | — | $-10.0M |
8季度趋势，按日历期对齐
经营现金流EQIXSOLV
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $95.0M | ||
| Q3 25 | $1.0B | $76.0M | ||
| Q2 25 | $944.0M | $169.0M | ||
| Q1 25 | $809.0M | $29.0M | ||
| Q4 24 | $981.0M | $219.0M | ||
| Q3 24 | $758.0M | $169.0M | ||
| Q2 24 | $912.0M | $355.0M |
自由现金流EQIXSOLV
| Q1 26 | — | — | ||
| Q4 25 | $-292.0M | $32.0M | ||
| Q3 25 | $-122.0M | $-21.0M | ||
| Q2 25 | $-45.0M | $59.0M | ||
| Q1 25 | $59.0M | $-80.0M | ||
| Q4 24 | $-6.0M | $92.0M | ||
| Q3 24 | $34.0M | $76.0M | ||
| Q2 24 | $264.0M | $297.0M |
自由现金流率EQIXSOLV
| Q1 26 | — | — | ||
| Q4 25 | -12.1% | 1.6% | ||
| Q3 25 | -5.3% | -1.0% | ||
| Q2 25 | -2.0% | 2.7% | ||
| Q1 25 | 2.7% | -3.9% | ||
| Q4 24 | -0.3% | 4.4% | ||
| Q3 24 | 1.5% | 3.7% | ||
| Q2 24 | 12.2% | 14.3% |
资本支出强度EQIXSOLV
| Q1 26 | — | — | ||
| Q4 25 | 59.3% | 3.2% | ||
| Q3 25 | 49.1% | 4.6% | ||
| Q2 25 | 43.8% | 5.1% | ||
| Q1 25 | 33.7% | 5.3% | ||
| Q4 24 | 43.7% | 6.1% | ||
| Q3 24 | 32.9% | 4.5% | ||
| Q2 24 | 30.0% | 2.8% |
现金转化率EQIXSOLV
| Q1 26 | — | — | ||
| Q4 25 | 4.32× | 1.51× | ||
| Q3 25 | 2.71× | 0.06× | ||
| Q2 25 | 2.57× | 1.88× | ||
| Q1 25 | 2.36× | 0.21× | ||
| Q4 24 | — | 7.06× | ||
| Q3 24 | 2.55× | 1.39× | ||
| Q2 24 | 3.03× | 3.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EQIX
暂无分部数据
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
